📰 Robert Barrow News
Page 5 - Robert Barrow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Barrow. Real-time updates on events, politics, business and more.
March 23, 2024
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have covered the stock in the […]
March 12, 2024
The maritime environment is one with logistics, not warfare, at its core. As someone who spent a career training for the latter, it pains me to say it, but this is the reality.
March 12, 2024
The maritime environment is one with logistics, not warfare, at its core. As someone who spent a career training for the latter, it pains me to say it, but this is the reality.
March 11, 2024
New research shows that a form of LSD may be an effective treatment for generalized anxiety disorder, with the FDA designating the drug as a breakthrough therapy.
March 1, 2024
Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) had its price objective raised by Royal Bank of Canada from $14.00 to $15.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has an outperform rating on the stock. Separately, Canaccord Genuity Group assumed coverage on Mind Medicine (MindMed) in a report on Tuesday, […]
February 27, 2024
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, February 28th. Analysts expect Mind Medicine (MindMed) to post earnings of ($0.48) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so […]
February 27, 2024
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have updated their coverage on […]
February 23, 2024
Breaking News, Sports, Manitoba, Canada
February 2, 2024
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on […]
February 1, 2024
FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address issues in drug development.